Patents Assigned to BIOMVIS SRL
  • Patent number: 12551544
    Abstract: The invention relates to gram-negative bacteria carrying gene-inactivating mutations that cause deletion of proteins belonging to the OMV proteome, to Outer Membrane Vesicles (OMVs) produced by these bacteria and immunogenic compositions thereof.
    Type: Grant
    Filed: April 16, 2020
    Date of Patent: February 17, 2026
    Assignee: BIOMVIS SRL
    Inventors: Guido Grandi, Alberto Grandi, Laura Fantappie', Ilaria Zanella, Enrico Koenig, Assunta Gagliardi
  • Patent number: 12054521
    Abstract: There are disclosed fusion proteins comprising the bacterial protein FhuD2 and one or more copies of a heterologous polypeptide, polynucleotides and expression vectors encoding the fusion proteins and bacterial outer membrane vesicles containing them. Other aspects of the invention regard immunogenic compositions comprising the outer membrane vesicles and their use in the prevention or treatment of tumors.
    Type: Grant
    Filed: March 7, 2019
    Date of Patent: August 6, 2024
    Assignee: BIOMVIS SRL
    Inventor: Alberto Grandi
  • Publication number: 20230390374
    Abstract: There is disclosed a method for the co-expression of multi-antigens in bacterial outer membrane vesicles, immunogenic compositions containing the isolated vesicles and the use thereof for the prevention or treatment of bacterial infections.
    Type: Application
    Filed: October 19, 2021
    Publication date: December 7, 2023
    Applicant: BIOMVIS SRL
    Inventors: Assunta Gagliardi, Alberto Grandi, Laura Fantappie'
  • Patent number: 11066453
    Abstract: The present invention provides means and products for the stimulation of an immune response against tumors in a subject in need thereof. More specifically the invention provides immunogenic compositions containing bacterial outer membrane vesicles loaded with tumor antigens, fusion proteins comprising a bacterial protein and a tumor antigen, and isolated bacterial outer membrane vesicles (OMVs) containing said fusion proteins. The fusion proteins, OMVs and immunogenic compositions according to the invention are used in the prevention and treatment of tumors.
    Type: Grant
    Filed: May 17, 2016
    Date of Patent: July 20, 2021
    Assignee: BIOMVIS SRL
    Inventors: Guido Grandi, Valeria Cafardi, Laura Fantappie′, Renata Grifantini, Alberto Grandi
  • Patent number: 11027004
    Abstract: This invention relates to outer membrane vesicles (OMVs) from Gram-negative bacteria. The vesicles comprise heterologous proteins or immunogenic fragments thereof expressed as lipoproteins in their membrane. The OMVs of the invention are capable of eliciting an immune response to the heterologous protein or to a fragment thereof when administered to a mammal. Other aspects of the invention relate to methods of preparing the OMVs and immunogenic compositions containing the same.
    Type: Grant
    Filed: October 23, 2017
    Date of Patent: June 8, 2021
    Assignee: BIOMVIS SRL
    Inventors: Guido Grandi, Laura Fantappie', Carmela Irene
  • Publication number: 20200405835
    Abstract: There are disclosed fusion proteins comprising the bacterial protein FhuD2 and one or more copies of a heterologous polypeptide, polynucleotides and expression vectors encoding the fusion proteins and bacterial outer membrane vesicles containing them. Other aspects of the invention regard immunogenic compositions comprising the outer membrane vesicles and their use in the prevention or treatment of tumors.
    Type: Application
    Filed: March 7, 2019
    Publication date: December 31, 2020
    Applicant: BIOMVIS SRL
    Inventor: Alberto Grandi